The FDA recently approved a new "transmucosal patch" called Onsolis. It is eerily similar to the deadly Fentanyl pain patch, which has caused the deaths of at least 1,000 people, according to the CDC.
How did this drug get FDA approval? It's a good question considering Onsolis appears to be a copycat of Fentanyl in terms of potency and delivery method.
"This could be very abuseable -- quick effects, easy to take," said Dr. Andrew Mannes of the National Institute of Health in Bethesda, Maryland.
The tepid response to a new Fentanyl-esque pain patch was echoed by Dr. Elliot Krane of Stanford University who said Onsolis probably won't provide "any unique or new therapeutic benefits over existing products."
To give you some background information, Fentanyl hit the market as a powerful pain reliever; so powerful that it's estimated to be 80 times stronger than morphine and hundreds of times more potent than heroin. It's so potent that the Russian military apparently used "a fentanyl derivative" against terrorists! Talk about a dangerous drug.
Numerous lawsuits were filed against the manufacturers of Fentanyl and we represented two families who tragically lost a spouse after a sudden overdose while wearing the prescribed Fentanyl pain patches.
Given the checkered past of this pain medication and delivery method, I have very little faith that Onsolis will be a good alternative. In fact, I'm extremely concerned we could see thousands more people seriously injured or even die after using these shoddy pain patches.